IL36G and psoriasis: This study reported that tacrolimus was successfully able to abrogate downstream targets of TNFα / IL‐17A‐induced IκBζ such as psoriasis‐associated genes IL‐36γ, CCL‐20, IL‐1β and S100‐A9.76